Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06847438 · ClinicalTrials.gov registry record · NA
Tailored Electronic Intervention to Improve Therapy in a Diverse Cohort of Patients With Heart Failure
A NA study of Heart Failure, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 4,000
- Enrollment target
- 4
- Study locations
NCT06847438: Recruiting NA study of Heart Failure, sponsored by Emory University.
NCT06847438 is a NA study of Heart Failure that is actively recruiting participants, run by Emory University. The registered enrollment target is 4,000 participants, above the 2,039-participant average among 397 other Heart Failure trials with a reported enrollment target (96% higher). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06847438, a NA study of Heart Failure, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 4,000 participants
- Enrollment target
- 4
- Study locations
Study Summary
Recent medical guidelines for the management of heart failure (HF) have established a combination of specific classes of medications as the best treatment for patients with heart failure with reduced ejection fraction (HFrEF). However, studies have shown that these medications, known together as guideline-directed medical therapy (GDMT), are not being used in clinical practice less often than they could be. Several tools to promote broader use of these treatments (including patient checklists) have shown promise for increasing use of GDMT. However, these tools have not been broadly implemented within large health systems. The goal of this study is to see if using these tools broadly within cardiology clinics will increase the use of GDMT. This study is important because it could help improve the use of GDMT, which may lead to improved patient care and outcomes.
Primary Outcome
Changes in medication are assessed as the initiation or intensification of recommended heart failure medications including foundational GDMTs (angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB)/angiotensin receptor neprilysin inhibitors (ARNI), beta-blockers (BB), mineralocorticoid receptor antagonists (MRA), and sodium glucose cotransporter-2 inhibitors (SGLT2i)) as well as other guideline recommended therapies for HFrEF including ivabradine, digoxin, and solubl
Conditions Studied
Interventions
- BEHAVIORAL Standard of Care
- BEHAVIORAL Optimized version of the EPIC-HF Checklist
- BEHAVIORAL Clinician-facing Decision Support
Study Locations (4)
Georgia
- Emory Saint Joseph's Hospital - Atlanta
- Emory University Hospital Midtown - Atlanta
- Emory University Hospital - Atlanta
- Emory Johns Creek Hospital - Johns Creek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2025-03-24 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT06847438 shows while recruiting
NCT06847438 is an interventional study that assigns participants to a tested intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,039-participant average among 397 other Heart Failure trials with a reported enrollment target (96% higher).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 3 interventions - of which Standard of Care is the first listed.
NCT06847438 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06847438 about?
NCT06847438 is a clinical study titled "Tailored Electronic Intervention to Improve Therapy in a Diverse Cohort of Patients With Heart Failure". Recent medical guidelines for the management of heart failure (HF) have established a combination of specific classes of medications as the best treatment for patients with heart failure with reduced ejection fraction (HFrEF). However, studies have shown that these medications, known together as gui...
What is the current status of trial NCT06847438?
This trial is currently recruiting. It is a NA study. The enrollment target is 4,000 participants. The study started on 2025-03-24. Estimated completion is 2026-06.
What conditions does trial NCT06847438 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT06847438?
The interventions under investigation include: Standard of Care (BEHAVIORAL), Optimized version of the EPIC-HF Checklist (BEHAVIORAL), Clinician-facing Decision Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT06847438?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06847438 being conducted?
This trial has 4 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06847438's enrollment target sits among peer trials
4,000 28th of 397 higher than 369 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI